🔗 Share this article

The pattern continues again.

During the first week of September, a group of unexplained fatalities among children in a rural community in Madhya Pradesh had local medical staff working urgently.

No fewer than eleven children - aged 1-6 years - succumbed within days of taking a common cough syrup. Officials examined everything from drinking water to mosquitoes before the cause was discovered: their kidneys had stopped functioning.

After investigation, a state laboratory in southern India verified the most alarming finding. The syrup under scrutiny was found to have 48.6% toxic solvent, a poisonous chemical that must not be present in medication. Kidney failure is frequent after ingesting this poisonous alcohol.

Widespread Emergency

The horror wasn't confined to the initial location. In neighbouring Rajasthan, the fatalities of two small kids, reportedly after consuming a locally-made cough suppressant - a cough suppressant unsafe for very young children - sparked outrage and a official probe.

For India, this brought a grim feeling of déjà vu.

Historically, diethylene glycol in domestically produced cold medicines has taken dozens of young lives. In last year, locally manufactured medicines tainted with diethylene glycol were linked to the deaths of 70 children in The Gambia and eighteen in Central Asia.

Between December 2019 and early 2020, no fewer than 12 children below five years succumbed in northern India allegedly from medication, with advocates indicating the total of casualties might have been greater. In the past, there's also been misuse of cough syrups containing codeine, a mild opioid that can produce pleasure in high doses and lead to dependence, and is not advised for young children.

Oversight Shortcomings

Whenever regulators promise reform, contaminated medicines resurface - reflecting a fragmented drug market and, experts claim, a weak regulatory system finding it difficult to oversee hundreds of low-cost, often unauthorized medications produced by smaller manufacturers and sold over the counter.

Shortly after the most recent fatalities, the nation's health ministry urged rational use of such medicines - essentially cautioning physicians to practice more caution when prescribing them to kids - confiscated samples of the medicine, halted and banned distribution, and initiated an investigation.

Industry Expansion and Healthcare Situation

However the issue, critics say, runs deeper than over-prescription. Every fresh incident reveals the flaws in the country's drug oversight framework - a maze of poor implementation and control. The Indian cough syrup industry is projected to soar from over two hundred million dollars in this year to nearly three quarters of a billion dollars by 2035, expanding at a compound annual rate of almost ten percent, as per market research.

But none of this would happen if the nation, and its citizens, could wean themselves off their obsession with cold medications. For many years, physicians have recommended them, and users have used them, even though most provide minimal benefit and can possibly do serious harm.

Advertised as quick relief for throat pain and stubborn coughs, these sweet syrups combine sweeteners, colour and flavorings with a cocktail of antihistamines, decongestants, expectorants.

Clinical Perspective

In theory, each ingredient has a function: one reduces mucus, another loosens phlegm, a different one suppresses the coughing impulse. In practice, research of them being effective is small - the majority of coughs resolve on their own in a short time.

A respiratory symptom can be caused by either bacterial/viral illness or an allergic reaction. Cold medications broadly fall into two categories - calming agents that enable the youngster rest, and bronchodilators that ease respiration - and doctors typically recommend one or the other, not a mix.

The majority of ongoing respiratory issues in children in increasingly polluted urban areas are not caused by illness but by allergies and inflammation of the respiratory tract, as per children's doctors. Hypersensitivity reactions occur when the body's defenses responds excessively to stimuli such as particles and pollution.

These youngsters often have a runny nose and a respiratory issue that worsens at night or dawn, repeating every several days. In urban centers, such repeating, wet coughs are typically triggered by dust and smog, sometimes accompanied by mild bronchospasm.

Management Methods

Doctors said these coughs respond best to bronchodilators - treatments that open up the airways - preferably through puffers or nebulisers, though many physicians continue using syrups that provide only minimal benefit.

The majority of pediatric respiratory issues are virus-caused, temporary, and clear on their own within a week. Physicians say no medication reduces their course; at best, they provide temporary comfort. At worst, they pose dangers of addiction, toxicity and overdose.

"I typically avoid recommend cold medications for common symptoms and respiratory infections - other than sometimes for symptom relief. If a youngster is severely symptomatic and can't sleep, I might administer a small amount of a mild medication just to ease the symptoms. The main goal is relief, not treatment, especially when the cough is dry and associated with a viral infection," explains a children's doctor.

Root Causes

What explains is medication so widely prescribed in India?

One reason is the deficiency of the nation's primary healthcare system, especially in smaller towns and rural areas. As rising air pollution worsens persistent respiratory issues, they are progressively misused for common respiratory infections.

The problem runs deeper in the rural regions. In villages, up to three-quarters of basic medical visits are handled by unqualified practitioners - frequently untrained "RMPs" without proper education.

In locations where the government medical facility is distant, under-staffed, or shut, they are the actual doctors - and syrups are their most trusted treatments. When working in Gorakhapur, a